ID
13237
Description
A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT01994837
Link
https://clinicaltrials.gov/show/NCT01994837
Keywords
Versions (1)
- 1/25/16 1/25/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
January 25, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Myelogenous Leukemia NCT01994837
Eligibility Acute Myelogenous Leukemia NCT01994837
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
anti-cancer therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C1522449
- UMLS CUI [3]
- C1531518
- UMLS CUI [4]
- C1875319
Description
monoclonal antibody
Data type
boolean
Alias
- UMLS CUI [1]
- C0003250
Description
CYP3A inducer
Data type
boolean
Alias
- UMLS CUI [1]
- C0059563
Description
cyp3a inhibitors
Data type
boolean
Alias
- UMLS CUI [1]
- C0059563
Description
leukocytes
Data type
boolean
Alias
- UMLS CUI [1]
- C0023508
Description
APL
Data type
boolean
Alias
- UMLS CUI [1]
- C0023487
Description
cns leukemia
Data type
boolean
Alias
- UMLS CUI [1]
- C1332884
Similar models
Eligibility Acute Myelogenous Leukemia NCT01994837
- StudyEvent: Eligibility
C1522449 (UMLS CUI [2])
C1531518 (UMLS CUI [3])
C1875319 (UMLS CUI [4])